N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.07p
  • 52 Week Low: 0.38p
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 277,145
  • Market Cap: £3.12m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £46,462
Luke Cairns 142,660 £535

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £562,500
Northern Standard Limited 150,000,000 £562,500
Mathenz Marc Kay 74,000,000 £277,500
Patrick Byrne 43,162,500 £161,859
David Farrier 28,000,000 £105,000
Peel Hunt LLP 7,436,152 £27,886
MYLES MCNULTY 4,000,000 £15,000
Lynchwood Nominees Limited 690,800 £2,590
Barclays Stockbrokers Limited 447,800 £1,679
LR Nominees Limited 311,600 £1,168

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.07p
52 Week Low 0.38p
Volume 277,145
Shares Issued 832.28m
Market Cap £3.12m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Value
51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Income Not Available
Growth
23.64% above the market average23.64% above the market average23.64% above the market average23.64% above the market average23.64% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 26-Jun-2025

Time Volume / Share Price
14:28 251,645 @ 0.40p
11:59 25,000 @ 0.40p
09:11 500 @ 0.40p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page